Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Migrastatics-Anti-metastatic and Anti-invasion Drugs: Promises and Challenges

A. Gandalovičová, D. Rosel, M. Fernandes, P. Veselý, P. Heneberg, V. Čermák, L. Petruželka, S. Kumar, V. Sanz-Moreno, J. Brábek,

. 2017 ; 3 (6) : 391-406.

Language English Country United States

Document type Journal Article, Review

Persistent link   https://www.medvik.cz/link/bmc18024878

Grant support
NV15-32432A MZ0 CEP Register

In solid cancers, invasion and metastasis account for more than 90% of mortality. However, in the current armory of anticancer therapies, a specific category of anti-invasion and antimetastatic drugs is missing. Here, we coin the term 'migrastatics' for drugs interfering with all modes of cancer cell invasion and metastasis, to distinguish this class from conventional cytostatic drugs, which are mainly directed against cell proliferation. We define actin polymerization and contractility as target mechanisms for migrastatics, and review candidate migrastatic drugs. Critical assessment of these antimetastatic agents is warranted, because they may define new options for the treatment of solid cancers.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18024878
003      
CZ-PrNML
005      
20180719131820.0
007      
ta
008      
180709s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.trecan.2017.04.008 $2 doi
035    __
$a (PubMed)28670628
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Gandalovičová, Aneta $u Department of Cell Biology, Charles University, Viničná 7, Prague, Czech Republic; Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (BIOCEV), Průmyslová 595, 25242, Vestec u Prahy, Czech Republic.
245    10
$a Migrastatics-Anti-metastatic and Anti-invasion Drugs: Promises and Challenges / $c A. Gandalovičová, D. Rosel, M. Fernandes, P. Veselý, P. Heneberg, V. Čermák, L. Petruželka, S. Kumar, V. Sanz-Moreno, J. Brábek,
520    9_
$a In solid cancers, invasion and metastasis account for more than 90% of mortality. However, in the current armory of anticancer therapies, a specific category of anti-invasion and antimetastatic drugs is missing. Here, we coin the term 'migrastatics' for drugs interfering with all modes of cancer cell invasion and metastasis, to distinguish this class from conventional cytostatic drugs, which are mainly directed against cell proliferation. We define actin polymerization and contractility as target mechanisms for migrastatics, and review candidate migrastatic drugs. Critical assessment of these antimetastatic agents is warranted, because they may define new options for the treatment of solid cancers.
650    _2
$a zvířata $7 D000818
650    _2
$a protinádorové látky $x chemie $x farmakologie $x terapeutické užití $7 D000970
650    _2
$a nádorové biomarkery $7 D014408
650    _2
$a pohyb buněk $x účinky léků $7 D002465
650    12
$a objevování léků $7 D055808
650    _2
$a chemorezistence $7 D019008
650    _2
$a synergismus léků $7 D004357
650    _2
$a lidé $7 D006801
650    _2
$a cílená molekulární terapie $7 D058990
650    _2
$a metastázy nádorů $x farmakoterapie $7 D009362
650    _2
$a nádory $x farmakoterapie $x etiologie $x metabolismus $x patologie $7 D009369
650    _2
$a signální transdukce $x účinky léků $7 D015398
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Rosel, Daniel $u Department of Cell Biology, Charles University, Viničná 7, Prague, Czech Republic; Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (BIOCEV), Průmyslová 595, 25242, Vestec u Prahy, Czech Republic.
700    1_
$a Fernandes, Michael $u Medbase, Chapel Hill, NC, USA.
700    1_
$a Veselý, Pavel $u Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic.
700    1_
$a Heneberg, Petr $u Charles University, Department of Internal Medicine, Third Faculty of Medicine, Prague, Czech Republic.
700    1_
$a Čermák, Vladimír $u Department of Cell Biology, Charles University, Viničná 7, Prague, Czech Republic; Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (BIOCEV), Průmyslová 595, 25242, Vestec u Prahy, Czech Republic.
700    1_
$a Petruželka, Luboš $u Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
700    1_
$a Kumar, Sunil $u Ayurveda Molecular Modeling, Hyderabad, Telangana, India.
700    1_
$a Sanz-Moreno, Victoria $u Tumor Plasticity Laboratory, Randall Division of Cell and Molecular Biophysics, Guy's Campus, King's College London, London, UK. Electronic address: victoria.sanz_moreno@kcl.ac.uk.
700    1_
$a Brábek, Jan $u Department of Cell Biology, Charles University, Viničná 7, Prague, Czech Republic; Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (BIOCEV), Průmyslová 595, 25242, Vestec u Prahy, Czech Republic. Electronic address: jan.brabek@natur.cuni.cz.
773    0_
$w MED00195479 $t Trends in cancer $x 2405-8033 $g Roč. 3, č. 6 (2017), s. 391-406
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28670628 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180709 $b ABA008
991    __
$a 20180719132121 $b ABA008
999    __
$a ok $b bmc $g 1317009 $s 1021799
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 3 $c 6 $d 391-406 $i 2405-8033 $m Trends in cancer $n Trends Cancer $x MED00195479
GRA    __
$a NV15-32432A $p MZ0
LZP    __
$a Pubmed-20180709

Find record

Citation metrics

Archiving options